XBIO
Xenetic Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.77
+12.60%Next report
Analyst consensus
- Next report date
- Nov 6, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.41
- EPS estimate
- —
- Revenue actual
- $660.6K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +30.0%
- Revenue beats (12Q)
- 6
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | — | -$0.41 | — | $660.6K |
| May 12, 2026 | — | -$0.20 | — | $806.9K |
| Mar 12, 2026 | -$0.52 | -$0.22 | Beat 57.69% | $766.3K |
| Nov 12, 2025 | -$0.49 | -$0.33 | Beat 32.65% | $1.0M |
| Aug 12, 2025 | -$0.64 | -$0.45 | Beat 29.69% | $589.9K |
| Aug 13, 2024 | -$0.83 | -$0.83 | In line | $726.4K |
| May 9, 2024 | -$0.79 | -$0.78 | Beat 1.27% | $510.8K |
| Mar 21, 2024 | -$0.87 | -$0.77 | Beat 11.49% | $672.0K |
| Nov 10, 2023 | -$1.12 | -$0.69 | Beat 38.39% | $611.2K |
| Aug 11, 2023 | -$1.13 | -$0.69 | Beat 38.94% | $651.0K |
| May 11, 2023 | -$1.10 | -$0.60 | Beat 45.45% | $605.8K |
| Mar 23, 2023 | -$0.09 | -$1.00 | Miss -1011.11% | $487.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 6, 2026